###begin article-title 0
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria
###end article-title 0
###begin p 1
Conceived and designed the experiments: ALC LS WCL KCK. Performed the experiments: ALC LS CF. Analyzed the data: ALC LS CF KCK. Contributed reagents/materials/analysis tools: SOO SK CDG WCL JMM KCK. Wrote the paper: ALC KCK. Organized collection of clinical samples and clinical data: SOO JMM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 486 494 486 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 58 64 <span type="species:ncbi:9606">infant</span>
Placental malaria (PM) is a leading cause of maternal and infant mortality. Although the accumulation of parasitized erythrocytes (PEs) and monocytes within the placenta is thought to contribute to the pathophysiology of PM, the molecular mechanisms underlying PM remain unclear. Based on the hypothesis that excessive complement activation may contribute to PM, in particular generation of the potent inflammatory peptide C5a, we investigated the role of C5a in the pathogenesis of PM in vitro and in vivo.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 177 198 177 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 204 206 204 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 177 198 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 698 703 <span type="species:ncbi:9606">women</span>
###xml 743 748 <span type="species:ncbi:9606">women</span>
###xml 808 813 <span type="species:ncbi:9606">women</span>
Using primary human monocytes, the interaction between C5a and malaria in vitro was assessed. CSA- and CD36-binding PEs induced activation of C5 in the presence of human serum. Plasmodium falciparum GPI (pfGPI) enhanced C5a receptor expression (CD88) on monocytes, and the co-incubation of monocytes with C5a and pfGPI resulted in the synergistic induction of cytokines (IL-6, TNF, IL-1beta, and IL-10), chemokines (IL-8, MCP-1, MIP1alpha, MIP1beta) and the anti-angiogenic factor sFlt-1 in a time and dose-dependent manner. This dysregulated response was abrogated by C5a receptor blockade. To assess the potential role of C5a in PM, C5a plasma levels were measured in malaria-exposed primigravid women in western Kenya. Compared to pregnant women without malaria, C5a levels were significantly elevated in women with PM.
###end p 5
###begin title 6
Conclusions and Significance
###end title 6
###begin p 7
These results suggest that C5a may contribute to the pathogenesis of PM by inducing dysregulated inflammatory and angiogenic responses that impair placental function.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Gilles1">[1]</xref>
###xml 333 336 333 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Diagne1">[2]</xref>
###xml 358 379 358 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 493 496 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Fried1">[3]</xref>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Fried1">[3]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Duffy1">[5]</xref>
###xml 62 68 <span type="species:ncbi:9606">infant</span>
###xml 320 327 <span type="species:ncbi:9606">infants</span>
###xml 358 379 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Placental malaria (PM) is a major determinant of maternal and infant health in the developing world. PM, especially in primigravidae, can have profound maternal and fetal health consequences, including anemia, stillbirth, premature delivery, intrauterine growth restriction (IUGR) and delivery of low birth weight (LBW) infants [1], [2]. The accumulation of Plasmodium falciparum parasitized erythrocytes (PEs) within the placenta is believed to be an essential step in the pathogenesis of PM [3]. A subpopulation of PEs that express novel variant surface antigens (VSA-PM), specifically adhere to glycosaminoglycan chondroitin sulfate A (CSA) in the placental intervillous space [3]-[5].
###end p 9
###begin p 10
###xml 228 230 226 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 268 271 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Abrams1">[6]</xref>
###xml 272 276 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Krishnegowda1">[10]</xref>
###xml 307 310 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Abrams1">[6]</xref>
###xml 312 316 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lucchi1">[11]</xref>
###xml 318 322 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lucchi2">[12]</xref>
###xml 656 659 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Abrams1">[6]</xref>
###xml 660 663 640 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Suguitan1">[8]</xref>
###xml 665 669 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lucchi2">[12]</xref>
###xml 671 675 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Chaisavaneeyakorn2">[13]</xref>
###xml 774 778 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Fried2">[14]</xref>
###xml 779 783 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rogerson2">[16]</xref>
PM is also characterized by the infiltration of the placenta with maternal mononuclear cells (mphi). The sequestered PEs release bioactive molecules including those with associated glycosylphosphatidylinositol anchor molecules (pfGPI) that can stimulate maternal mphi [6]-[10] and fetal syncytiotrophoblast [6], [11], [12] to produce inflammatory cytokines, such as TNF and IFN-gamma, and beta-chemokines including macrophage-inflammatory protein (MIP)-1alpha, MIP-1beta, monocyte chemoattractant protein-1 (MCP-1), and macrophage migration inhibitory factor (MIF). These cytokines and chemokines further recruit, retain, and activate mphi in the placenta [6]-[8], [12], [13]. The resultant accumulation of activated mphi is believed to contribute to adverse birth outcomes [14]-[16]. Although PEs and mphi collect in the placenta, how they may contribute to fetal and placental injury is unknown.
###end p 10
###begin p 11
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Caucheteux1">[17]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Bowen1">[18]</xref>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 416 417 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Fried2">[14]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rogerson2">[16]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Marzi1">[19]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Hunt1">[20]</xref>
The maintenance of regulated cytokine responses in the placenta is essential in order to prevent rejection of the semiallogenic fetoplacental unit and ensure appropriate immunological responses to infection [17]. This involves a generalized physiological adaptation that results in a bias towards cytokines promoting humoral immunity at the expense of cell-mediated immunity [18]. PM is associated with heightened TH1-type responses that disrupt the balance of cytokines at the maternal-fetal interface [14], [16], [19], [20]. However, the molecular basis underlying PM-associated cytokine dysregulation, placental immunopathology, and adverse birth outcomes is incompletely understood.
###end p 11
###begin p 12
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-HuberLang1">[21]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-HuberLang1">[21]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-HuberLang2">[23]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-HuberLang1">[21]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Chenoweth1">[26]</xref>
###xml 943 947 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Aird1">[27]</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Pober1">[28]</xref>
###xml 1151 1155 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Smedegard1">[29]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-HuberLang3">[31]</xref>
The complement system is an essential component of the innate immune response to a number of infectious agents. The complement cascade can be activated by four distinct pathways, three of which converge at the level of the C3 component, leading to the cleavage of C3 and C5 to their activated forms, C3a and C5a, as well as the formation of the terminal membrane attack complex [21], [22]. Recently, a pathway of C5a generation occurring independently of C3 was described [21], [23]. Several lines of evidence have implicated excessive activation of the complement system, notably generation of the potent pro-inflammatory peptide C5a, in mediating deleterious innate host responses to bacterial and fungal infections and contributing to the development of sepsis (reviewed in [22]) [21]-[26]. Sepsis, similar to severe malaria, is a clinical syndrome characterized by systemic inflammation and endothelial activation in response to infection [27], [28]. Elevated C5a levels in sepsis have been implicated in adverse clinical outcomes and death. Blockade of C5a-C5aR activity in animal models of sepsis prevents end-organ injury and improves survival [29]-[31].
###end p 12
###begin p 13
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Girardi1">[32]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-CharnockJones1">[33]</xref>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Levine1">[34]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Zhou1">[36]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Girardi1">[32]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Muehlenbachs1">[37]</xref>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 795 800 <span type="species:ncbi:9606">women</span>
Excessive C5a generation has also recently been identified as a critical mediator of placental and fetal injury in a non-infectious mouse model of spontaneous miscarriage and IUGR, via dysregulation of angiogenic factors required for normal placental development [32]. Activated complement components were shown to directly induce the release of soluble fms-like tyrosine kinase-1 (sFlt-1, sVEGFR-1), a potent anti-angiogenic factor that prevents signaling of vascular endothelial growth factor and placental growth factor [33]. Excessive levels of sFlt-1 inhibit placental differentiation and are thought to play a direct role in pre-eclampsia [34]-[36] and C5a-associated IUGR and pregnancy loss [32]. Of note, Muehlenbachs et al. have reported elevated plasma levels of sFlt-1 in primigravid women with PM [37].
###end p 13
###begin p 14
###xml 378 380 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 462 475 462 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 484 492 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 462 475 <span type="species:ncbi:5833">P. falciparum</span>
###xml 515 520 <span type="species:ncbi:9606">women</span>
Based on the hypothesis that C5a may play a role in PM by generating angiogenic factors that mediate IUGR and fetal loss, we determined whether malaria parasites can activate C5 and if C5a potentiates the induction of sFlt-1, inflammatory cytokines and chemokines associated with adverse pregnancy outcomes. Here we show that CSA- and CD36-binding PEs activate C5, that C5a and pfGPI cooperate to induce an amplified inflammatory and anti-angiogenic response to P. falciparum malaria in vitro, and that primigravid women with PM have elevated circulating C5a levels in vivo.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 0 13 <span type="species:ncbi:5833">P. falciparum</span>
P. falciparum culture
###end title 16
###begin p 17
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Patel1">[38]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Serghides1">[39]</xref>
The laboratory isolates CS2 (CSA-binding) and E8B (ICAM-1 and CD36 binding) were cultured in vitro as described [38], [39]. Cultures were routinely treated with mycoplasma removal agent (ICN), and were tested and found negative for mycoplasma by PCR.
###end p 17
###begin title 18
Mononuclear cell isolation
###end title 18
###begin p 19
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-McGilvray1">[40]</xref>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 406 407 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PBMCs were isolated from healthy volunteers using a Ficoll gradient as previously described [40]. PBMCs were counted using a haemocytometer and cell viability was determined by Trypan blue exclusion test. Cells were plated at a concentration of 2.0x106 cells/mL (48 well plate) in RPMI 1640 medium supplemented with 10% heat inactivated FBS and gentamycin (R10G). Cells were cultured at 37degreesC in 5% CO2 for the time indicated.
###end p 19
###begin title 20
###xml 40 53 40 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 40 53 <span type="species:ncbi:5833">P. falciparum</span>
Isolation and purification of GPIs from P. falciparum
###end title 20
###begin p 21
###xml 14 27 14 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Naik1">[41]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Krishnegowda1">[10]</xref>
###xml 305 307 305 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 14 27 <span type="species:ncbi:5833">P. falciparum</span>
HPLC-purified P. falciparum GPI (pfGPI) was isolated [41], conjugated to gold beads and used at a concentration of 300 ng/ml as previously described [10]. Unconjugated gold beads alone were added as controls to wells containing media, or C5a (endotoxin-free; Biovision, USA). All preparations of purified pfGPIs were tested for endotoxin by Limulus amebocyte lysate assay prior to use.
###end p 21
###begin title 22
Complement assays
###end title 22
###begin p 23
###xml 242 247 <span type="species:ncbi:9606">human</span>
PEs, uninfected red blood cells (uRBCs), or media control were incubated in the presence of 30% serum from malaria naive donors. After 30 min, supernatants were collected and analyzed for C5 activation. C5a levels in culture supernatants and human plasma were measured by ELISA (R&D Systems).
###end p 23
###begin title 24
Cytokine and chemokine assays
###end title 24
###begin p 25
###xml 73 86 73 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Ward1">[25]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Solomkin1">[42]</xref>
###xml 469 471 469 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 73 86 <span type="species:ncbi:5833">P. falciparum</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
PBMCs were cultured with or without recombinant human C5a in addition to P. falciparum culture supernatants (1:10 dilution) and R10G alone as media control, or HPLC-purified GPI (300 ng/mL) and unconjugated gold beads as a control. C5a concentrations ranging from 1 nM to 100 nM were selected representing a spectrum of C5a levels ranging from physiologically normal levels (<10 nM) to those associated with sepsis (10-100 nM) [25], [42]. For receptor blockade studies pfGPI, the C5aR blocking antibody (Serotec, S5/1, 5 microg/mL) or an isotype control (eBioscience, eBM2a, 5 microg/mL) was added to culture medium just prior to stimulation with 50 nM C5a. Culture supernatants were collected aseptically at times indicated. IL-6, TNF, IL-1beta, and IL-10 were measured by Cytometric Bead Array (CBA) (BD Biosciences, human inflammation kit). IL-8, monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein-1alpha and - beta (MIP-1alpha and MIP-1beta) and sFlt-1 (sVEGFR-1) were measured by ELISA (R&D Systems).
###end p 25
###begin title 26
Flow cytometry
###end title 26
###begin p 27
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
PBMCs (2.0x106) were blocked in 20% serum for 20 min at 4degreesC. Cells were then stained for CD14-APC (eBioscience, 61D3, 100 uL/mL) and CD88-PE or isotype IgG1-PE (BD Biosciences, D53-1473, 150 uL/mL and eBioscience, P3, 150 uL/mL) for 30 min at 4degreesC. Cells were fixed in 1% paraformaldehyde/PBS overnight and analyzed on a Becton Dickinson FACS Calibur flow cytometer. Data was analyzed using FlowJo software. A minimum of 50,000 events were collected. Positive background PE staining in isotype samples was subtracted from respective CD88-PE stained samples and then reported as specific CD88 staining.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 716 718 714 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 755 757 753 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 841 843 839 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1060 1062 1058 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1430 1455 1428 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004953.s001">Supporting Information S1</xref>
###xml 1457 1459 1455 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004953.s002">S2</xref>
###xml 1461 1463 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004953.s003">S3</xref>
###xml 1465 1467 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004953.s004">S4</xref>
Data are expressed as means+/-SEM, unless otherwise noted. For continuous variables a Student's t test or one-way ANOVA with Bonferonni post-tests was used to compare means. Non-parametric tests (Mann-Whitney or Kruskall-Wallis) were used to compare groups where parametric test conditions were not met. Synergism was determined by the interaction term of a two way ANOVA (C5a*GPI). Synergism in the time course was determined using the cumulative cytokine levels after 48 hours by performing a two way ANOVA and examining the interaction term. Significance in the C5a receptor blockade experiments was assessed by repeated measures ANOVA to determine whether levels of cytokines differed between cells treated with pfGPI alone, or anti-CD88 plus C5a and pfGPI, or student's t-test by comparing the isotype and anti-CD88 co-treated (C5a and pfGPI) groups after correcting for the background levels observed in media controls. In cases where C5a receptor blockade resulted in values of "0", a one sample t-test was used to determine whether the isotype C5a and pfGPI co-treated groups differed from a hypothetical value of "0". Correlation of peripheral parasitemia to placental parasitemia was determined using Spearman correlation. Experiments were performed in duplicate or triplicate and repeated as indicated in the figure legends. Statistical analysis of experimental replicates is found in the supporting information files (Supporting Information S1, S2, S3, S4). Differences with p<0.05 were considered significant. Statistical analysis was performed using GraphPad Prism and SPSS.
###end p 29
###begin title 30
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 30
###begin p 31
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Chaisavaneeyakorn1">[7]</xref>
###xml 111 116 <span type="species:ncbi:9606">women</span>
###xml 577 582 <span type="species:ncbi:9606">Women</span>
###xml 607 610 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 884 896 <span type="species:ncbi:9606">participants</span>
Plasma samples were collected at time of delivery from the peripheral blood and placental blood of primigravid women, living in an area of holoendemic malaria transmission in Western Kenya, with and without placental malaria infection as described previously [7]. Malaria infection was evaluated by examination of Giemsa-stained peripheral and placental thick and thin blood smears by light microscopy. Percent parasitemia was estimated by counting a minimum of 1000 erythrocytes and calculated using the following formula: (# infected erythrocytes/total # erythrocytes) x100. Women who tested positive for HIV were excluded. This study was approved by the institutional review boards of the University of Georgia, the Kenya Medical Research Institute and the Centers for Disease Control and Prevention, Atlanta, Georgia, United States. Written informed consent was obtained from all participants.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
CSA- and CD36-binding PEs activate C5 and pfGPI induces C5a receptor expression
###end title 33
###begin p 34
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Ward1">[25]</xref>
###xml 411 420 411 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g001"><bold>Figure 1A</bold></xref>
The pro-inflammatory anaphylatoxin C5a has been implicated in mediating deleterious host responses to bacterial and fungal agents [22], [25]. To confirm that CSA-binding PEs were capable of activating the complement system and thus generating C5a, serum from malaria-naive donors was added to mature stage CS2 PEs or uRBCS. Compared to uRBCs or controls, C5 activation was only observed in the presence of PEs (Figure 1A) (mean C5a levels: CS2 PEs 24.77 ng/mL [95% confidence interval (CI) 2.229-47.30], E8B PEs 26.19 ng/ml [95% CI -10.44-62.82], uRBCs 7.114 ng/mL [95% CI 5.922-8.306], control 7.242 ng/mL [95% CI 4.116-10.37]; CS2 PEs vs. uRBCs p<0.001 Student's t-test). Non-PM PEs (E8B) also activated C5 (E8B PEs vs. uRBCs p<0.001 Student's t-test).
###end p 34
###begin title 35
###xml 56 58 56 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
Parasitized erythrocytes (PEs) induce C5 activation and pfGPI upregulates C5aR expression on monocytes.
###end title 35
###begin p 36
###xml 569 571 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 785 787 783 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 536 541 <span type="species:ncbi:9606">Human</span>
(A) Serum from malaria-naive donors was added to mature stage CS2 (CSA binding) PEs or E8B (ICAM-1 and CD36 binding), uninfected red blood cells (uRBCs) or media for 30 min and supernatants were assayed for C5a by ELISA. Increased C5a levels were observed in the supernatants of PEs compared to uRBC or control, (Student's t-test: uRBCs vs. Mature PEs ***p<0.001). Data are presented as means+/-SEM and are representative of four independent experiments for CS2 parasites and two independent experiments for CD36-binding parasites. (B) Human PBMCs were stimulated with pfGPI or unconjugated gold beads alone as a control for 24 h. Expression of C5a receptor was determined by flow cytometry on monocytes (CD14). The percentage of monocytes expressing C5aR was significantly higher for pfGPI-treated versus media control cells, (Student's t-test: *p = 0.0279). Data are presented as means+/-SEM and are representative of two independent experiments.
###end p 36
###begin p 37
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Monk1">[43]</xref>
###xml 194 196 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 271 273 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 509 518 509 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 509 518 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g001"><bold>Figure 1B</bold></xref>
###xml 573 575 573 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
In order to respond to activated C5, cells must express a C5a receptor. Previous studies report that C5a responsiveness increases following cellular stimulation [43]. To determine the effect of pfGPI on monocyte C5aR (CD88) expression, PBMCs were incubated as above with pfGPI or media control for 24 or 48 hours, and C5aR and CD14 expression (used to define monocytes) was determined by flow cytometry. Compared to media only control cells, a significant increase in the number of monocytes expressing C5aR (Figure 1B) was observed (mean: media 1.2% [95% CI -0.2-2.7] vs. pfGPI 3.0 [95% CI 1.5-4.4] p = 0.0279 by Student's t-test). The density of the C5aR, as determined by the mean fluorescent intensity on monocytes already expressing the receptor, was unchanged (data not shown).
###end p 37
###begin title 38
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
C5a potentiates pfGPI-induced inflammatory responses
###end title 38
###begin p 39
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Ward1">[25]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Albrecht1">[44]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Zhu1">[45]</xref>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Krishnegowda1">[10]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Albrecht1">[44]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Niederbichler1">[46]</xref>
###xml 371 373 371 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 698 713 698 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A and B</bold>
###xml 698 713 698 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g002"><bold>Figure 2A and B</bold></xref>
###xml 476 481 <span type="species:ncbi:9606">human</span>
C5a has been shown to enhance TLR-mediated pro-inflammatory responses to microbial products such as LPS, contributing to sepsis syndromes [22], [25], [44], [45]. The parasite product pfGPI is recognized by TLR2 and is believed to be a mediator of the inflammatory response that characterizes severe malarial syndromes [10], [44]-[46]. To assess whether C5a would amplify pfGPI-induced pro-inflammatory responses, we treated PBMCs with increasing concentrations of recombinant human C5a (0, 1, 5, 10, 50, and 100 nM) with or without pfGPI for 24 hours and determined the production of IL-6 and TNF by ELISA. We observed a dose-dependent potentiation of pfGPI-induced IL-6 and TNF production by C5a (Figure 2A and B; two-way ANOVA (C5a*GPI), p<0.0001).
###end p 39
###begin title 40
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
C5a potentiates pfGPI-induced inflammatory cytokines in a dose-dependent manner.
###end title 40
###begin p 41
###xml 137 139 137 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 306 308 306 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Human PBMCs were stimulated with varying concentrations of recombinant human C5a (0, 1, 5, 10, 50, 100 nM) for 24 hours, with or without pfGPI. Culture supernatants were collected and assayed for IL-6 (A) and TNF (B) by ELISA. Data were analyzed by two-way ANOVA and demonstrate an interaction effect (C5a*pfGPI) for IL-6 (***p<0.0001) and for TNF (***p<0.0001). Data are presented as means+/-SEM of three independent experiments.
###end p 41
###begin title 42
C5a Receptor blockade inhibits enhanced cytokine responses
###end title 42
###begin p 43
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Fried2">[14]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rogerson2">[16]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Moormann1">[47]</xref>
###xml 181 183 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 254 256 254 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 631 633 631 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 753 764 750 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A&#8211;D</bold>
###xml 753 764 750 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003"><bold>Figure 3A&#8211;D</bold></xref>
###xml 764 765 761 762 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">:</bold>
###xml 1078 1089 1072 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3E&#8211;H</bold>
###xml 1078 1089 1072 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003"><bold>Figure 3E&#8211;H</bold></xref>
###xml 1089 1090 1083 1084 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">:</bold>
###xml 1271 1273 1265 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1418 1420 1409 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
Elevated levels of TH1 cytokines have been implicated in PM pathogenesis and adverse pregnancy outcomes [14], [16], [47]. In order to determine the effect of C5a on the kinetics of pfGPI-induced cytokine production, we treated PBMCs with C5a (50 nM) and pfGPI (HPLC-purified, 300 ng/mL) for 48 hours. Supernatants were collected at baseline, 1, 2, 4, 6, 8, 12, 24 and 48 hours and assayed for inflammatory cytokines using a cytometric bead array. To examine the role of C5a-C5aR interactions in the observed inflammatory responses, we also performed parallel experiments including monoclonal antibody blockade of the C5a receptor. pfGPI-stimulated cytokines, including IL-6, TNF, IL-1beta and IL-10, were synergistically induced in the presence of C5a (Figure 3A-D: two-way ANOVA on cumulative cytokine levels (C5a*GPI); p<0.0001 for IL-6, p = 0.0124 for TNF, p = 0.0418 for IL-1beta and p<0.0001 for IL-10). A significant reduction in cytokine production was observed in experiments using anti-C5aR blocking antibody compared to its isotype control for all cytokines measured (Figure 3E-H: repeated measures ANOVA). Further analysis (repeated measures ANOVA) was performed to determine whether C5aR blockade returned cytokine production to levels for cells treated with pfGPI alone. In the presence of anti-C5aR, production of IL-6, TNF, and IL-1beta was returned to levels that were not significantly different from pfGPI alone (p>0.05). However, this was not true for IL-10 (p = 0.0101).
###end p 43
###begin title 44
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
C5a potentiates pfGPI-induced inflammatory cytokines and this effect is abrogated by C5a receptor blockade.
###end title 44
###begin p 45
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 300 302 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 779 781 765 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1177 1179 1153 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 559 564 <span type="species:ncbi:9606">Human</span>
Human PBMCs were cultured with unconjugated gold beads (media control), unconjugated gold beads and C5a (50 nM), pfGPI (300 ng/mL), or a combination of C5a and pfGPI. (A-D) Supernatants were assayed for IL-6 (A), TNF (B), IL-1beta (C), and IL-10 (D). A significant interaction effect between C5a and pfGPI was observed for all cytokines tested. p<0.0001 for IL-6, p = 0.0124 for TNF, p = 0.0418 for IL-1beta and p<0.0001 for IL-10 (by two-way ANOVA on cumulative cytokine production over 48 h). Data are representative of three independent experiments. (E-H) Human PBMCs were treated with an alpha-CD88 mAb (5 microg/mL) to block the C5a receptor or an appropriate isotype control and exposed to either unconjugated gold beads (media control) or a combination of C5a (50 nM) and pfGPI (300 ng/mL) for 48 h. Supernatants were assayed for IL-6 (E), TNF (F), IL-1beta (G) and IL-10 (H). Cytokine production was significantly reduced upon C5a receptor blockade; p = 0.0005 for IL-6, p = 0.0028 for TNF, p = 0.0479 for IL-1beta and p = 0.0191 for IL-10 (repeated measures ANOVA comparing cytokine levels between isotype control mAb and alpha-CD88 mAb groups co-treated with C5a and pfGPI). Values shown are corrected for background levels observed in the media controls, and are presented as means+/-SEM. Data are representative of two independent experiments.
###end p 45
###begin title 46
C5a potentiates secretion of chemokines and the angiogenesis inhibitor sFlt-1
###end title 46
###begin p 47
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rogerson1">[15]</xref>
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Menendez1">[48]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Moore1">[49]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Girardi1">[32]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Muehlenbachs1">[37]</xref>
###xml 485 487 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 690 698 683 691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 690 698 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>Figure 4</bold></xref>
###xml 716 718 709 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1007 1018 993 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A&#8211;E</bold>
###xml 1007 1018 993 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>Figure 4A&#8211;E</bold></xref>
###xml 1018 1019 1004 1005 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">:</bold>
###xml 1236 1266 1215 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004953.s004">supporting information file S4</xref>
The infiltration of monocytes into the placenta during PM is associated with adverse birth outcomes [15], [48], [49]. Furthermore, elevated levels of the anti-angiogenic factor sFlt-1 (sVEGFR-1) have been causally implicated in placental dysfunction, growth restriction and fetal loss [32], [37]. In order to determine whether C5a could potentiate the induction of chemokines involved in the recruitment of monocytes and the anti-angiogenic factor sFlt-1, we incubated PBMCs with C5a, pfGPI, or media controls with or without C5aR blocking antibody or an isotype control antibody and measured IL-8 (CXCL8), MCP-1 (CCL2), MIP-1alpha (CCL3), MIP-1beta (CCL4), and sFlt-1 (sVEGFR-1) by ELISA (Figure 4). In the C5a and pfGPI co-treated group, synergistic induction of all factors was observed by two-way ANOVA (C5a*GPI; p = 0.0265 for IL-8, p = 0.0010 for MCP-1, and p<0.0001 for MIP-1 alpha, MIP-1beta and sFlt-1). Blocking C5aR inhibited the augmented secretion of all chemokines with the exception of IL-8 (Figure 4A-E: Student's t-test p = 0.0388for MCP-1, p = 0.0005 for MIP1-alpha, p = 0.0002 for MIP1-beta). Blockade of the C5aR reduced levels of sFlt-1, but the differences did not consistently reach statistical significance (see supporting information file S4).
###end p 47
###begin title 48
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
C5a potentiates secretion of pfGPI-induced chemokines and the anti-angiogenic factor sFlt-1.
###end title 48
###begin p 49
###xml 119 121 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 166 168 166 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 347 349 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 500 502 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human PBMCs were treated with either unconjugated gold beads (media control), unconjugated gold beads and C5a (50 nM), pfGPI (300 ng/mL), or a combination of C5a and pfGPI for 48 h. Where indicated PBMCs were treated with either 5 microg/mL of alpha-CD88 mAb to block the C5a receptor or an appropriate isotype control and were exposed to C5a and pfGPI. Supernatants were assayed for IL-8 (A), MCP-1 (B), MIP-1alpha (C), MIP-1beta (D) and sFlt-1 (E). A significant interaction effect between C5a and pfGPI was observed; *p = 0.0265 for IL-8, **p = 0.0010 for MCP-1, * p = 0.0177 for sFlt-1, and ***p<0.0001 for MIP-1 alpha, and MIP-1beta (by two-way ANOVA). C5a receptor blockade significantly reduced the levels of MCP-1 (* p = 0.0388), MIP-1alpha (*** p = 0.0005), and MIP-1beta (*** p = 0.0002) (by student's t-test). Data are presented as means+/-SEM and are representative of three independent experiments.
###end p 49
###begin title 50
C5a is increased in PM and is associated with higher placental parasite burdens
###end title 50
###begin p 51
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 109 116 109 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 109 116 109 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t001"><bold>Table 1</bold></xref>
###xml 116 121 116 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 121 122 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t002"><bold>2</bold></xref>
###xml 329 338 329 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 329 339 329 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g005"><bold>Figure 5A</bold>:</xref>
###xml 610 619 610 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 610 620 610 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g005"><bold>Figure 5B</bold>:</xref>
###xml 1074 1081 1074 1081 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1074 1081 1074 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t001"><bold>Table 1</bold></xref>
###xml 1081 1086 1081 1086 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 1086 1087 1086 1087 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t002"><bold>2</bold></xref>
###xml 102 107 <span type="species:ncbi:9606">women</span>
###xml 190 193 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 215 220 <span type="species:ncbi:9606">women</span>
###xml 314 319 <span type="species:ncbi:9606">women</span>
###xml 595 600 <span type="species:ncbi:9606">women</span>
###xml 896 901 <span type="species:ncbi:9606">women</span>
###xml 924 929 <span type="species:ncbi:9606">women</span>
In order to extend our observations to the in vivo setting, we examined C5a levels in malaria-exposed women (Table 1 and 2). We analyzed C5a levels in the peripheral and placental plasma of HIV negative primigravid women with or without PM from Kisumu, Kenya. Peripheral C5a levels were significantly increased in women with PM (Figure 5A: mean C5a levels; PM negative: 98.85 ng/mL [95% CI 84.14-113.6] vs. PM positive: 147.1 ng/mL [95% CI 96.81-197.3] p = 0.01 by Student's t-test two-tailed test on log transformed data). Furthermore, C5a was significantly elevated in the placental plasma of women with PM (Figure 5B: mean C5a levels; PM negative: 69.07 ng/mL [95% CI 58.17-79.98] vs. PM positive: 104.0 ng/mL [95% CI 73.10-135.0] p = 0.0264 by Student's t-test two-tailed test on log transformed data). No significant differences were observed between the ages of PM positive vs. PM negative women; however, primigravid women with PM had significantly lower hemoglobin levels, consistent with the destruction of maternal erythrocytes associated with malarial infection (Table 1 and 2).
###end p 51
###begin title 52
###xml 12 17 <span type="species:ncbi:9606">women</span>
Primigravid women with placental malaria (PM) have increased levels of C5a in peripheral and placental plasma.
###end title 52
###begin p 53
###xml 96 99 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 121 126 <span type="species:ncbi:9606">women</span>
###xml 322 327 <span type="species:ncbi:9606">women</span>
###xml 509 514 <span type="species:ncbi:9606">women</span>
C5a levels were assayed in peripheral and placental plasma by ELISA. Samples were obtained from HIV negative primigravid women at time of delivery in Kisumu, western Kenya. C5a levels were significantly higher in (A) peripheral plasma of placenta malaria positive (PM+, n = 21) vs. placenta malaria negative (PM-, n = 45) women, *p = 0.01 by two-tailed Student's t-test on log transformed data; and (B) in placenta plasma of placenta malaria positive (PM+, n = 24) vs. placenta malaria negative (PM-, n = 47) women, *p = 0.0264 by Student's t-test two-tailed test on log transformed data.
###end p 53
###begin title 54
###xml 19 24 <span type="species:ncbi:9606">women</span>
Characteristics of women tested for C5a in peripheral blood.
###end title 54
###begin p 55
Abbreviations: Hemoglobin (g/dL), % parasitemia (% infected: non-infected erythrocytes), Hemozoin % Score (# pigment containing WBC/ 300WBC).
###end p 55
###begin p 56
p<0.001 (Student's t-test).
###end p 56
###begin title 57
###xml 19 24 <span type="species:ncbi:9606">women</span>
Characteristics of women tested for C5a in placental blood.
###end title 57
###begin p 58
Abbreviations: Hemoglobin (g/dL), % parasitemia (% infected: non-infected erythrocytes), Hemozoin % Score (# pigment containing WBC/ 300WBC).
###end p 58
###begin p 59
p<0.001 (Student's t-test).
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 279 287 279 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 279 287 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g001"><bold>Figure 1</bold></xref>
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 456 465 456 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 2</bold>
###xml 456 465 456 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g002"><bold>Figures 2</bold></xref>
###xml 465 467 465 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 467 468 467 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</bold>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003"><bold>3</bold></xref>
###xml 468 469 468 469 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&amp;</bold>
###xml 469 470 469 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</bold>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>4</bold></xref>
###xml 554 563 554 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3</bold>
###xml 554 563 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003"><bold>Figures 3</bold></xref>
###xml 563 564 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&amp;</bold>
###xml 564 565 564 565 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</bold>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>4</bold></xref>
###xml 604 611 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 733 741 733 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 733 741 733 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g005"><bold>Figure 5</bold></xref>
###xml 639 644 <span type="species:ncbi:9606">women</span>
This study provides the first evidence implicating excessive activation of the complement component C5 and the induction of anti-angiogenic factors in the pathogenesis of PM. We demonstrate that PEs and parasite products (pfGPI) activated C5 and induced C5a receptor expression (Figure 1). Further, C5a and pfGPI induced synergistic production of inflammatory cytokines, chemokines and an anti-angiogenic factor associated with adverse pregnancy outcomes (Figures 2, 3&4). A role for C5a-C5aR was confirmed by inhibiting inflammation with C5aR blockade (Figures 3&4). These findings were extended to the in vivo setting, where primigravid women with PM were shown to have elevated C5a levels in both peripheral and placental plasma (Figure 5).
###end p 61
###begin p 62
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Guo1">[22]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Ward1">[25]</xref>
The generation of C5a is normally tightly controlled and, under physiological conditions, C5a enhances the effector function of macrophages and neutrophils, contributing to effective innate responses to microbial pathogens [22]. However, detectable systemic C5a suggests a loss of regulation of complement activation. Elevated C5a levels are associated with a number of deleterious impacts on host innate defence, including defects in phagocyte and endothelial cell function, potentiated chemokine and cytokine secretion to bacterial components such as LPS, and lymphoid apoptosis (reviewed in [22], [25]).
###end p 62
###begin p 63
###xml 270 272 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
There are several mechanisms by which malaria may induce excessive complement activation, thereby contributing to the pathophysiologic mechanisms underlying PM. We observed that mature stage PEs are capable of generating C5a and a bioactive product of parasite rupture, pfGPI can result in an increase in monocytes expressing the C5aR. These observations suggest the potential for an autocrine loop, resulting in augmented inflammatory and angiogenic responses that may act in concert to mediate or amplify placental and fetal injury.
###end p 63
###begin p 64
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Roestenberg1">[50]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Yamada1">[52]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Roestenberg1">[50]</xref>
###xml 344 354 344 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Patel2">[53]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Muehlenbachs2">[54]</xref>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 344 354 <span type="species:ncbi:5821">P. berghei</span>
Our observations of malaria-induced C5a are consistent with studies of severe malaria and experimental malaria challenge models that report activation of the complement system [50]-[52]. In experimental human malaria infection, complement activation was observed prior to microscopic detection of parasitemia [50]. Similarly, a recent study of P. berghei ANKA implicated C5a as an early mediator of experimental cerebral malaria [53]. In the latter study, C5a levels were elevated prior to the onset of symptoms suggesting a role for C5a as an initiating or amplifying factor in malaria pathogenesis. Our observations are further supported by the findings of a recent genome-wide analysis of PM, where selected complement genes as well as C5aR were shown to be upregulated [54].
###end p 64
###begin p 65
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Riedemann2">[55]</xref>
###xml 171 173 171 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Krishnegowda1">[10]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Patel3">[56]</xref>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
During sepsis the excess activation of C5 has been associated with enhanced secretion of pro-inflammatory mediators in response to TLR ligands such as LPS [55]. Similarly pfGPI has been shown to induce inflammatory mediators in a TLR2-dependant manner [10], [56]. Additional studies will be needed to determine if the synergistic induction of inflammatory and angiogenic factors observed with pfGPI-C5a are also TLR-dependent.
###end p 65
###begin p 66
###xml 7 15 7 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 301 303 301 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 445 446 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Hawlisch1">[57]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rittirsch1">[58]</xref>
###xml 586 588 586 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 676 678 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 727 729 727 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 740 749 740 749 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 740 749 740 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003"><bold>Figure 3D</bold></xref>
###xml 789 796 789 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 879 880 876 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 880 881 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 987 991 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Kabyemela1">[59]</xref>
In our in vitro model, C5aR blockade abrogated the potentiated inflammatory responses that are believed to be central to the pathogenesis of PM. However, a different response was observed for IL-10. While IL-10 production was reduced by C5aR blockade, the levels did not return to those observed with pfGPI alone. We speculate that this may be attributable to the expression of the alternate C5a receptor, C5L2, which has been shown to promote TH2 skewing [57] as well as have inflammatory effects in experimental sepsis [58]. Future studies will be required to investigate the role of pfGPI and other parasite products on the expression of C5L2. When cells were treated with pfGPI and C5a, IL-10 was induced earlier than with pfGPI alone (Figure 3D). This may have important implications in vivo since TGF-beta and IL-10 regulate inflammatory responses. Early IL-10 may impair TH1-mediated parasite clearance during malaria infection and increased IL-10 levels have been reported in PM [59].
###end p 66
###begin p 67
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Rogerson1">[15]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Menendez1">[48]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Moore1">[49]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Leopardi1">[60]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Ordi1">[61]</xref>
###xml 447 451 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Moormann1">[47]</xref>
###xml 611 614 601 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Abrams1">[6]</xref>
###xml 616 619 606 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Suguitan1">[8]</xref>
###xml 660 664 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lucchi1">[11]</xref>
###xml 666 670 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lucchi3">[62]</xref>
###xml 699 701 689 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 817 828 804 815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A&#8211;D</bold>
###xml 817 828 804 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>Figure 4A&#8211;D</bold></xref>
###xml 1052 1054 1039 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1095 1097 1082 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 144 151 <span type="species:ncbi:9606">infants</span>
Monocyte infiltration into the placental intervillous space has been associated with poor birth outcomes including the risk of low birth weight infants [15], [48], [49], [60], [61]. Chemokines function as specific chemoattractants for leukocytes. IL-8 plays a role in neutrophil and monocyte migration, while the beta-chemokines are involved in macrophage migration. High levels of macrophage-derived IL-8 during PM have been associated with IUGR [47]. Elevated levels of MIP-1alpha, MIP-1beta and MCP-1 have been observed in PM and it is likely that these chemokines are derived from both maternal (leukocyte) [6], [8] and fetal (syncytiotrophoblast) sources [11], [62]. As with cytokines, C5a and pfGPI synergistically induced chemokines, and this effect was abrogated for the beta-chemokines by blocking the C5aR (Figure 4A-D). No significant difference for IL-8 production was found between cells treated with anti-C5aR versus an isotype control due to the variation in the latter group. However, there was no difference between cells treated with pfGPI alone or with anti-C5aR plus C5a and pfGPI, indicating that blocking the C5aR inhibits the effect attributable to C5a.
###end p 67
###begin p 68
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Brabin1">[63]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Jansson1">[64]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Dorman1">[65]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-CharnockJones1">[33]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Levine1">[34]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Zhou1">[36]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Lam1">[35]</xref>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Girardi1">[32]</xref>
###xml 1027 1029 1027 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pf</italic>
###xml 1261 1270 1261 1270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 1261 1270 1261 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004"><bold>Figure 4E</bold></xref>
###xml 1331 1335 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLT1</italic>
###xml 1478 1486 1478 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1486 1490 1486 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Muehlenbachs3">[66]</xref>
###xml 1646 1650 1646 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Muehlenbachs3">[66]</xref>
###xml 1433 1438 <span type="species:ncbi:9606">women</span>
Peak prevalence of malaria infection during pregnancy occurs between 13-20 weeks gestation and gradually falls as gestation increases [63]. This coincides with the second wave of trophoblast invasion of the maternal spiral arteries (16-18 weeks). It is hypothesized that PM may impair transformation of the maternal vasculature leading to placental dysfunction [64], [65]. One protein that may play a role in impaired angiogenesis is the anti-angiogenic factor sFlt-1. This alternatively spliced soluble variant of VEGFR-1 binds and sequesters placental growth factor and vascular endothelial growth factor. Excess sFlt-1 has been shown to inhibit placental cytotrophoblast differentiation and invasion [33]. Increased sFlt-1 levels have been implicated in the pathogenesis of placentation associated with pre-eclampsia and IUGR [34]-[36] and have been shown to predict the development of pre-eclampsia [35]. sFlt-1 can be produced extra-placentally by monocytes treated with C5a [32]. Therefore, we determined whether C5a and pfGPI would potentiate sFlt-1 production from mononuclear cells. We show that sFlt-1 was synergistically induced by co-stimulation with these molecules and that this effect was reduced but not consistently inhibited by C5aR blockade (Figure 4E). We postulate this may be due to different PBMC donors, as FLT1 genotype has been associated with differing sFlt-1 levels in the peripheral blood of primigravid women, as well as PBMC responsiveness to LPS in vitro[66]. Furthermore, the study by Muehlenbachs et al., provides the first evidence that both fetal and maternal genotype may contribute to immune responses to PM [66]. Taken together, these data suggest a putative mechanism for impaired angiogenesis and placental dysfunction during PM.
###end p 68
###begin p 69
###xml 289 296 289 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t001"><bold>Table 1</bold></xref>
###xml 296 297 296 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 297 298 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004953-t002"><bold>2</bold></xref>
###xml 369 370 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 370 379 370 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g005"><bold>Figure 5A</bold></xref>
###xml 379 380 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 406 415 406 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 406 415 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g005"><bold>Figure 5B</bold></xref>
###xml 415 416 415 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">women</span>
###xml 262 267 <span type="species:ncbi:9606">women</span>
###xml 429 434 <span type="species:ncbi:9606">women</span>
###xml 543 548 <span type="species:ncbi:9606">women</span>
In order to extend these observations to human infection, we measured C5a levels in the peripheral blood of a cohort of malaria-exposed primigravid Kenyan women and we measured C5a levels in the placental blood of a similar cohort of malaria-exposed primigravid women at time of delivery (Table 1-2) Significantly increased levels of C5a were found in peripheral blood (Figure 5A) and the placental blood (Figure 5B) of pregnant women with PM compared to those without. These results provide the first evidence that C5a levels are elevated in women with PM. However, these findings will need to be confirmed in larger prospective clinical studies. It will be of interest to also examine how C5a levels change with respect to other disease parameters, including parasitemia and mononuclear cell infiltrates in larger populations.
###end p 69
###begin p 70
###xml 248 256 248 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 248 256 248 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g006"><bold>Figure 6</bold></xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004953-Hillmen1">[67]</xref>
In summary, we have demonstrated a role for C5a in the enhanced cytokine and chemokine responses that characterize PM and in the induction of sFlt-1, an anti-angiogenic factor associated with abnormal placental development and poor birth outcomes (Figure 6). Our findings that disruption of the C5a-C5aR interaction inhibits inflammatory and anti-angiogenic responses to malaria suggest anti-C5a-C5aR strategies as potential therapeutic approaches for PM [67].
###end p 70
###begin title 71
Proposed mechanism for C5a-mediated dysregulation of the placental environment in PM.
###end title 71
###begin p 72
###xml 283 296 283 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 283 296 <span type="species:ncbi:5833">P. falciparum</span>
###xml 568 575 <span type="species:ncbi:9606">infants</span>
Mature schizonts activate C5 and rupture releasing parasite components containing GPI that induce expression of C5aR and activate macrophages. The concomitant expression of C5aR and generation of C5a represent a potential autocrine mechanism by which C5a can amplify inflammation in P. falciparum malaria resulting in the excessive cytokine and chemokine responses that characterize PM. The dysregulated production of cytokines, chemokines and the anti-angiogenic factor sFlt-1 contribute to placental dysfunction, intrauterine growth restriction and low birth weight infants.
###end p 72
###begin title 73
Supporting Information
###end title 73
###begin p 74
###xml 39 54 39 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g001">Figure 1A and B</xref>
Experimental replicates and statistics Figure 1A and B
###end p 74
###begin p 75
(0.03 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 39 48 39 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g002">Figure 2B</xref>
Experimental replicates and statistics Figure 2B (TNF)
###end p 77
###begin p 78
(0.03 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 39 47 39 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g003">Figure 3</xref>
Experimental replicates and statistics Figure 3
###end p 80
###begin p 81
(0.04 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 39 47 39 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004953-g004">Figure 4</xref>
Experimental replicates and statistics Figure 4
###end p 83
###begin p 84
(0.05 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 115 120 <span type="species:ncbi:9606">women</span>
We thank the Director of the Kenya Medical Research Institute for his permission to publish this work, and all the women who participated in this study.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
Malaria, anaemia and pregnancy.
###end article-title 88
###begin article-title 89
###xml 42 47 <span type="species:ncbi:9606">women</span>
Incidence of clinical malaria in pregnant women exposed to intense perennial transmission.
###end article-title 89
###begin article-title 90
###xml 13 34 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.
###end article-title 90
###begin article-title 91
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection.
###end article-title 91
###begin article-title 92
###xml 73 94 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype.
###end article-title 92
###begin article-title 93
Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression.
###end article-title 93
###begin article-title 94
###xml 121 126 <span type="species:ncbi:9606">women</span>
###xml 154 182 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection.
###end article-title 94
###begin article-title 95
###xml 70 75 <span type="species:ncbi:9606">women</span>
###xml 81 102 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria.
###end article-title 95
###begin article-title 96
Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors.
###end article-title 96
###begin article-title 97
###xml 94 115 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity.
###end article-title 97
###begin article-title 98
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast.
###end article-title 98
###begin article-title 99
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 55 76 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum.
###end article-title 99
###begin article-title 100
###xml 92 113 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas.
###end article-title 100
###begin article-title 101
###xml 40 45 <span type="species:ncbi:9606">human</span>
Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes.
###end article-title 101
###begin article-title 102
###xml 46 67 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes.
###end article-title 102
###begin article-title 103
###xml 133 138 <span type="species:ncbi:9606">women</span>
Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women.
###end article-title 103
###begin article-title 104
At the innate frontiers between mother and fetus: linking abortion with complement activation.
###end article-title 104
###begin article-title 105
###xml 124 129 <span type="species:ncbi:9606">women</span>
Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women.
###end article-title 105
###begin article-title 106
###xml 96 101 <span type="species:ncbi:9606">human</span>
Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy.
###end article-title 106
###begin article-title 107
Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells.
###end article-title 107
###begin article-title 108
Generation of C5a in the absence of C3: a new complement activation pathway.
###end article-title 108
###begin article-title 109
Role of C5a in inflammatory responses.
###end article-title 109
###begin article-title 110
Generation of C5a by phagocytic cells.
###end article-title 110
###begin article-title 111
The enigma of sepsis.
###end article-title 111
###begin article-title 112
The dark side of C5a in sepsis.
###end article-title 112
###begin article-title 113
###xml 49 54 <span type="species:ncbi:9606">human</span>
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
###end article-title 113
###begin article-title 114
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.
###end article-title 114
###begin article-title 115
Evolving functions of endothelial cells in inflammation.
###end article-title 115
###begin article-title 116
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Endotoxin-induced shock in the rat. A role for C5a.
###end article-title 116
###begin article-title 117
Protective effects of C5a blockade in sepsis.
###end article-title 117
###begin article-title 118
Role of C5a in multiorgan failure during sepsis.
###end article-title 118
###begin article-title 119
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
###end article-title 119
###begin article-title 120
Placental vascular morphogenesis.
###end article-title 120
###begin article-title 121
Circulating angiogenic factors and the risk of preeclampsia.
###end article-title 121
###begin article-title 122
Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.
###end article-title 122
###begin article-title 123
###xml 71 76 <span type="species:ncbi:9606">human</span>
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
###end article-title 123
###begin article-title 124
Hypertension and maternal-fetal conflict during placental malaria.
###end article-title 124
###begin article-title 125
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages.
###end article-title 125
###begin article-title 126
Placental chondroitin sulfate A-binding malarial isolates evade innate phagocytic clearance.
###end article-title 126
###begin article-title 127
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance.
###end article-title 127
###begin article-title 128
###xml 40 61 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Glycosylphosphatidylinositol Anchors of Plasmodium falciparum: Molecular Characterization and Naturally Elicited Antibody Response That May Provide Immunity to Malaria Pathogenesis.
###end article-title 128
###begin article-title 129
Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
###end article-title 129
###begin article-title 130
Function, structure and therapeutic potential of complement C5a receptors.
###end article-title 130
###begin article-title 131
Complement-induced impairment of the innate immune system during sepsis.
###end article-title 131
###begin article-title 132
###xml 94 115 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines and nitric oxide.
###end article-title 132
###begin article-title 133
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
###end article-title 133
###begin article-title 134
Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation.
###end article-title 134
###begin article-title 135
The impact of placental malaria on gestational age and birth weight.
###end article-title 135
###begin article-title 136
Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria.
###end article-title 136
###begin article-title 137
###xml 38 43 <span type="species:ncbi:9606">human</span>
Complement activation in experimental human malaria infection.
###end article-title 137
###begin article-title 138
###xml 32 53 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Complement activation in severe Plasmodium falciparum malaria.
###end article-title 138
###begin article-title 139
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study.
###end article-title 139
###begin article-title 140
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.
###end article-title 140
###begin article-title 141
Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection.
###end article-title 141
###begin article-title 142
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
###end article-title 142
###begin article-title 143
###xml 48 69 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Disruption of CD36 Impairs Cytokine Response to Plasmodium falciparum Glycosylphosphatidylinositol and Confers Susceptibility to Severe and Fatal Malaria In Vivo.
###end article-title 143
###begin article-title 144
The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.
###end article-title 144
###begin article-title 145
Functional roles for C5a receptors in sepsis.
###end article-title 145
###begin article-title 146
Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria.
###end article-title 146
###begin article-title 147
Malaric placentas. A quantitative study and clinico-pathological correlations.
###end article-title 147
###begin article-title 148
Massive chronic intervillositis of the placenta associated with malaria infection.
###end article-title 148
###begin article-title 149
###xml 39 44 <span type="species:ncbi:9606">human</span>
LPS induces secretion of chemokines by human syncytiotrophoblast cells in a MAPK-dependent manner.
###end article-title 149
###begin article-title 150
An analysis of malaria in pregnancy in Africa.
###end article-title 150
###begin article-title 151
Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.
###end article-title 151
###begin article-title 152
Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria.
###end article-title 152
###begin article-title 153
Natural selection of FLT1 alleles and their association with malaria resistance in utero.
###end article-title 153
###begin article-title 154
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
###end article-title 154
###begin p 155
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 155
###begin p 156
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 217 222 <span type="species:ncbi:9606">women</span>
###xml 353 358 <span type="species:ncbi:9606">women</span>
Funding: This work was supported by CIHR Team Grant in Malaria (KCK), operating grant MT-13721 (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK; WCL). Recruitment of women in Kenya was supported by NIH RO1050240 (JMM) and could not have been possible without the invaluable participation of parturient women and dedicated Kenyan staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 156

